tag@treatmentactiongroup.org

Letters

Petition to NYC Board of Health to Commence Emergency Rulemaking to Make Concrete Rules to End Racism As Public Health Peril

On June 25, 2020, the National Black Leadership Commission on Health, the Latino Commission on AIDS, Housing Works, and TAG petitioned the New York City Board of Health to institute concrete rules to end racism as a public health crisis in New York City. TAG and partners called on the Board of Health to convene an emergency session to adopt new rules, amendments, and policies to address the disparate impact of COVID-19 on Black and Latinx New Yorkers, address racism as a public health crisis, address over-policing, and improve public health and safety.
Read more

Appeal to UAE Authorities to Release Prisoners with HIV Vulnerable to COVID-19

On May 18th, TAG and 46 other organizations and individuals – including the Stop TB Partnership, Global Coalition of TB Activists, and regional networks of people living with HIV, people affected by TB, and people who use drugs – are sending this letter to authorities in the United Arab Emirates (UAE) with an urgent appeal concerning the health of people with HIV in UAE prisons who are vulnerable to COVID-19.
Read more

Open Letter to the Diagnostics Supply Consortium

On 24 April 2020, advocates sent an open letter to the Diagnostics Supply Consortium calling for a higher level of global coordination, transparency, and accountability to ensure sustainable and equitable access to molecular diagnostic testing for COVID-19...
Read more

TAG and TB CAB Letters Urging Pharmaceutical Companies to Register Their Respective Linezolid Products with the Medicines Control Council (MCC) in South Africa

TAG and the TB CAB signed on to open letters to several manufacturers of U.S. Food and Drug Administration (FDA)-approved generic linezolid, including Pfizer, Teva, Glenmark, Alkem, Amneal, Macleods, Apotex, Hetero, and Sanofi urging the companies to register their respective linezolid products with the Medicines Control Council (MCC) in South Africa. Registration of additional linezolid products will address the existing effective market monopoly and extremely high prices that prevent linezolid from being offered to all patients who could benefit from its use in South Africa and countries like Swaziland that rely on the South African regulatory approval system. The co-signatories asked that following registration, companies provide linezolid at the price currently offered to country programs through the Global Drug Facility (GDF).
Read more

Appeals to legislators to prioritize tuberculosis (TB) in plans for fiscal year 2017

TAG and other U.S.-based NGOs and civil society groups sent several appeals to legislators to prioritize tuberculosis (TB) in plans for fiscal year 2017 in line with the White House’s recently released National Action Plan for Combating Multidrug-Resistant Tuberculosis. Letters to three key House and Senate subcommittees—the Labor, Health and Human Services, Education, and Related Agencies Subcommittee, the Defense Subcommittee, and the Subcommittee on State, Foreign Operations, and Related Programs.
Read more

TAG Comment in Response to Proposed Rulemaking: Visas: Ineligibility Based on Public Charge Grounds

As an organization dedicated to ensuring equitable access to critical health services to individuals and communities affected by HIV/AIDS, tuberculosis (TB), and hepatitis C virus (HCV), Treatment Action Group (TAG) strongly opposes the proposed changes regarding “public charge,” published in the Federal Register on October 11, 2019 (the proposed rule).
Read more
Back To Top